BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Dr Reddys Laboratories Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
500124
ISIN Demat
INE089A01031
Book Value (Rs)
377.5510998
NSE Symbol
DRREDDY
Divident Yield %
0.62
Market Cap
(Rs In Cr.)
107,942
P/E (TTM)
23.26
EPS (TTM)
55.59
Face Value
(Rs)
1
Back
Dr Reddy's Laboratories consolidated net profit declines 14.42% in the December 2025 quarter
21-Jan-26   Hrs IST

Net profit of Dr Reddy's Laboratories declined 14.42% to Rs 1209.90 crore in the quarter ended December 2025 as against Rs 1413.70 crore during the previous quarter ended December 2024. Sales rose 4.41% to Rs 8727.00 crore in the quarter ended December 2025 as against Rs 8358.60 crore during the previous quarter ended December 2024.

ParticularsQuarter Ended
Dec. 2025Dec. 2024% Var.
Sales8727.008358.60 4
OPM %21.6327.19 -
PBDT2064.202345.70 -12
PBT1543.201874.30 -18
NP1209.901413.70 -14

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)